Cargando…

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases

BACKGROUND: Interstitial lung diseases (ILD) encompass a heterogenous group of diffuse parenchymal lung disorders characterized by variable degrees of inflammation and fibrosis. Pretherapeutic clinical testing models for such diseases can serve as a platform to test and develop effective therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dsouza, Kevin G., Surolia, Ranu, Kulkarni, Tejaswini, Li, Fu Jun, Singh, Pooja, Zeng, Huaxiu, Stephens, Crystal, Kumar, Abhishek, Wang, Zheng, Antony, Veena B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045174/ https://www.ncbi.nlm.nih.gov/pubmed/36978076 http://dx.doi.org/10.1186/s12931-023-02404-7

Ejemplares similares

Rifampicin Pulmospheres for Pulmonary Delivery
por: Morde, M. A., et al.
Publicado: (2009)

Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases
por: Surolia, Ranu, et al.
Publicado: (2022)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family
por: Estrella, Deborah dos Reis, et al.
Publicado: (2021)

Antifibrotic in interstitial lung diseases: When, where, and how long?
por: Rai, Deependra K., et al.
Publicado: (2022)

NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns
por: Surolia, Ranu, et al.
Publicado: (2021)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
por: Liang, Minrui, et al.
Publicado: (2022)

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
por: Boleto, Gonçalo, et al.
Publicado: (2022)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Heme Oxygenase-1 Protects Corexit 9500A-Induced Respiratory Epithelial Injury across Species
por: Li, Fu Jun, et al.
Publicado: (2015)

A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
por: Sugino, Keishi, et al.
Publicado: (2021)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
por: Liendo-Martínez, Katiuska Herminia, et al.
Publicado: (2023)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
por: Nawa, Hideki, et al.
Publicado: (2022)

Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling
por: Gu, Linlin, et al.
Publicado: (2021)

Antifibrotic drugs as therapeutic tools in resistant melanoma
por: Sanchez‐Laorden, Berta, et al.
Publicado: (2022)

Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
por: Salvi, Sundeep Santosh, et al.
Publicado: (2022)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic
por: Gazdhar, Amiq, et al.
Publicado: (2013)

Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents
por: Itano, Junko, et al.
Publicado: (2020)

In Vitro and In Vivo Antifibrotic Effects of Fraxetin on Renal Interstitial Fibrosis via the ERK Signaling Pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
por: Bos, Saskia, et al.
Publicado: (2021)

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
Publicado: (2022)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)

Discovery and evaluation of inhibitor of LARP6 as specific antifibrotic compound
por: Stefanovic, Branko, et al.
Publicado: (2019)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis
por: Taweesedt, Pahnwat, et al.
Publicado: (2023)

Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models
por: Nono, Justin Komguep, et al.
Publicado: (2020)

Heme Oxygenase-1 Promotes Granuloma Development and Protects Against Dissemination of Mycobacteria
por: Regev, Doron, et al.
Publicado: (2012)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
por: Westra, Inge M., et al.
Publicado: (2014)

Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
por: Hadda, Vijay, et al.
Publicado: (2020)

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice
por: Künzel, Stephan R., et al.
Publicado: (2023)

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
por: Kolb, Martin, et al.
Publicado: (2022)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

Antifibrotic function of cGKI in the kidney
por: Schlossmann, Jens, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v33c23sl0jdf7l0dm6r3a6nqqa